Search results: Found 63

Listing 1 - 10 of 63 << page
of 7
>>
Sort by
Treatment of Micropollutants in Water and Wastewater

Authors: ---
ISBN: 9781843393160 Year: Language: English
Publisher: IWA Publishing Grant: Knowledge Unlatched - 102468
Added to DOAB on : 2019-02-06 08:17:52
License:

Loading...
Export citation

Choose an application

Abstract

Treatment of Micropollutants in Water and Wastewater gives a comprehensive overview of modern analytical methods and will summarize novel single and hybrid methods to remove continuously emerging contaminants - micropollutants from the aqueous phase. New trends (e.g. sensor technology, nanotechnology and hybrid treatment technologies) are described in detail. The content of the book is divided into chapters that present current descriptive and analytical methods that are available to detect and measure micropollutants together with detailed information on various chemical, biological and physicochemical methods that have evolved over the last few decades. The provides an understanding of why and how micropollutants must be removed from water sources, and what are the most appropriate and available techniques for providing a cost and technologically effective and sustainable solutions for reaching the goal of micropollutant-free water and wastewater.

Public Involvement in Knowledge Generation

Authors: ---
ISBN: 9781789060492 Year: Language: English
Publisher: IWA Publishing
Subject: Environmental Technology
Added to DOAB on : 2019-08-13 11:21:02
License:

Loading...
Export citation

Choose an application

Abstract

Public Involvement in Knowledge Generation is an Open Access co-publication with KWR.&#xD;

Future drinking water infrastructure

Authors: --- --- ---
ISBN: 9781789060485 Year: Language: English
Publisher: IWA Publishing
Subject: Environmental Technology
Added to DOAB on : 2019-08-13 11:21:02
License:

Loading...
Export citation

Choose an application

Abstract

Future Drinking Water Infrastructure is an Open Access co-publication with KWR.&#xD;

Role of Intravenous Levetiracetam in Acute Seizure Management

Author:
Book Series: Frontiers Research Topics ISSN: 16648714 ISBN: 9782889193226 Year: Pages: 74 DOI: 10.3389/978-2-88919-322-6 Language: English
Publisher: Frontiers Media SA
Subject: Neurology --- Medicine (General)
Added to DOAB on : 2016-02-05 17:24:33
License:

Loading...
Export citation

Choose an application

Abstract

Intractable epilepsy still remains the main issue despite new advances in medical and surgical treatment of epilepsy. Acute seizure management in a timely manner is crucial to prevent irreversible brain damage. Benzodiazepines still remain the first initial treatment to abort the seizure activity. The approval phenytoin, fosphenytoin, intravenous valproate, and rectal diazepam provided additional options. The approval of intravenous levetiracetam gave another option to physicians if and when the above treatment fails to control the seizure activity. In this Ebook, we have included chapters from renowned researchers in the field of neurology and epilepsy who have covered the various aspects of these agents in detail including the properties, mechanism of action, pharmacology, neurobehavioral effects, and the roles of these agents in special populations including traumatic brain injury and brain tumor related epilepsy. These data further show that intravenous levetiracetam can be used in acute seizure management and in special circumstances.

Non-Pharmacological Interventions for Schizophrenia: How Much Can Be Achieved and How?

Authors: ---
Book Series: Frontiers Research Topics ISSN: 16648714 ISBN: 9782889450091 Year: Pages: 94 DOI: 10.3389/978-2-88945-009-1 Language: English
Publisher: Frontiers Media SA
Subject: Psychology --- Science (General)
Added to DOAB on : 2017-07-06 13:27:36
License:

Loading...
Export citation

Choose an application

Abstract

The introduction of antipsychotic agents in the 1950’s substantially improved the treatment of schizophrenia and other psychotic disorders. However, clinical and functional outcomes are still far less than optimal for patients, and have not improved in recent years despite the development of several new antipsychotics. Efficacy rates are further compromised by medication non-adherence, which has been reported to affect more than half of patients. In response to these issues, several non-pharmacological interventions have been developed for the treatment of schizophrenia, such as cognitive behavioral therapy, cognitive remediation, social cognition training and metacognitive approaches. Although these interventions have produced promising results, there is still much controversy regarding their usefulness and applicability in clinical practice. A major impeding factor for their dissemination is possibly a lack of sufficient evidence regarding their specific indications, mechanisms of action, adverse effects, but also practical issues concerning the interpretability of respective clinical studies, such as the choice of outcome variables and control of confounding factors. The present Research Topic includes original research articles and reviews addressing these issues.

Soccer Fitness (Book chapter)

Book title: Science and Football VIII

Author:
ISBN: 9781138947061 9781315670300 Year: Pages: 12 Language: English
Publisher: Taylor & Francis
Subject: Law
Added to DOAB on : 2017-09-27 11:02:13
License:

Loading...
Export citation

Choose an application

Abstract

The present chapter will provide an overview of the existing literature and a description of the relationship between the training elements of Soccer Fitness, the training-induced effects of Soccer Fitness on cardiovascular, metabolic and musculoskeletal fitness, and the potential of Soccer Fitness for the prevention and treatment of lifestyle diseases

Emerging Enterobacteriaceae Infections: Antibiotic Resistance and Novel Treatment Options

Author:
Book Series: Frontiers Research Topics ISSN: 16648714 ISBN: 9782889451890 Year: Pages: 115 DOI: 10.3389/978-2-88945-189-0 Language: English
Publisher: Frontiers Media SA
Subject: Microbiology --- Science (General)
Added to DOAB on : 2017-10-13 14:57:01
License:

Loading...
Export citation

Choose an application

Abstract

Enterobacteriaceae are spread worldwide and the diseases they cause may be fatal especially in immunocompromised patients. Moreover, the high prevalence of ESBL producing Salmonella and Shigella species diseases worldwide suggests major underlying safety issues. According to the World Health Organization (WHO), 2015, approximately 220 million children contract diarrhoeal diseases every year and 96 000 die. As a result, the increase in single or multi drug-resistant foodborne bacterial pathogens is of major public health concern. Moreover, resistance to antimicrobials was found among Salmonella spp and Campylobacter spp from animals and food, and since fluoroquinolones became licensed for use in animal foods, especially for poultry, the rate of fluoroquinolone resistant Salmonella spp and Campylobacter spp in animals and human food, and then in human infections, rapidly increased. To that purpose, the findings of the conducted studies in the book chapters, 1) highlight surveillance studies reporting the occurrence and distribution of resistance to antimicrobial agents, namely, to third generation cephalosporins, carbapenems and fluoroquinolones, 2) describe the mechanisms of transmission of resistance determinants from animals, food products and clinical specimens, that allow implementation of appropriate measures to control their spread and adopt appropriate therapeutic measures, and 3) provide treatment options, useful to medical practice.

Diagnosis and Surgical Treatment of Epilepsy

Author:
ISBN: 9783038974499 / 9783038974505 Year: Pages: 134 DOI: 10.3390/books978-3-03897-450-5 Language: English
Publisher: MDPI - Multidisciplinary Digital Publishing Institute
Subject: Biology
Added to DOAB on : 2019-01-09 11:37:07
License:

Loading...
Export citation

Choose an application

Abstract

Epilepsy is a common neurological disease that can affect all ages. Although the majority of people with epilepsy can have excellent seizure control with medication, about 30% will fail anti-epileptic drugs. For those with medically intractable epilepsy, recurrent seizures lead to elevated mortality and injury risks, and the seizures themselves are socially disabling. Fortunately, for many people with intractable epilepsy, epilepsy can be cured or seizures better controlled with surgery.Localization of the seizure focus followed by surgical resection provide the best opportunities to cure epilepsy. Having a better understanding of the neuro-anatomy and physiology of epilepsy improves our ability to define the epileptic network and effectively treat epilepsy. Minimal access surgical approaches result in more rapid recovery from surgery, less pain, and more satisfied patients.For individuals without an opportunity to cure their epilepsy, new and emerging technologies can improve their quality of life by preventing injuries and reducing seizure frequency and severity.This Special Issue will highlight advances in the diagnosis and surgical treatment of epilepsy, including imaging and electroencephalography (EEG) approaches to defining the epileptic focus, understanding the epileptic network, and characterizing the anatomical substrate of epilepsy.

Anaerobic Digestion

Authors: --- --- --- --- et al.
Book Series: Frontiers Research Topics ISSN: 16648714 ISBN: 9782889456796 Year: Pages: 152 DOI: 10.3389/978-2-88945-679-6 Language: English
Publisher: Frontiers Media SA
Subject: Science (General) --- Microbiology --- General and Civil Engineering --- Biotechnology --- Environmental Sciences
Added to DOAB on : 2019-01-23 14:53:43
License:

Loading...
Export citation

Choose an application

Abstract

Anaerobic digestion (AD) is a naturally-occurring biological process in soils, sediments, ruminants, and several other anoxic environments, that cycles carbon and other nutrients, and converts organic matter into a methane-rich gas. As a biotechnology, AD is now well-established for the treatment of the organic fraction of various waste materials, including wastewaters, but is also increasingly applied for an expanding range of organic feedstocks suitable for biological conversion to biogas. AD applications are classified in various ways, including on the basis of bioreactor design; and operating parameters, such as retention time, temperature, pH, total solids (TS) and volatile solids (VS) contents, and biodegradability of substrates. AD is an attractive bioenergy and waste / wastewater treatment technology. The advantages of AD for waste treatment include: production of a useable fuel (biogas/methane); possibility of high organic loading; reduced carbon footprint; and suitability for integration into a wide variety of process configurations and scales. Specifically, two important, and developing, applications exemplify the potential of AD technologies: (1) the integration of AD as the basis of the core technologies underpinning municipal wastewater, and sewage, treatment, to displace less sustainable, and more energy-intensive, aerobic biological treatment systems in urban water infrastructures; and (2) technical innovations for higher-rate conversions of high-solids wastestreams, and feedstocks, for the production of energy carriers (i.e. methane-biogas, but possibly also biohydrogen) and other industrially-relevant intermediates, such as organic acids.Internationally, the research effort to maximize AD biogas yield has increased ten-fold over the past decade. Depending on the feedstocks, bioreactor design and process parameters, fundamental and applied knowledge are still required to improve conversion rates and biogas yields. This Research Topic cover aspects related to AD processes, such as the effect of feedstock composition, as well as the effect of feedstock pre-treatment, bioreactor design and operating modes, on process efficiency; microbial community dynamics and systems biology; influence of macro- and micro-nutrient concentrations and availability; process control; upgrading and calibration of anaerobic digestion models (e.g. ADM1) considering the biochemical routes as well as the hydrodynamics in such ecosystems; and novel approaches to process monitoring, such as the development, and application, of novel, and rapid diagnostic assays, including those based on molecular microbiology. Detailed full-scale application studies were also particularly welcomed.

Central Nervous System Metastases in Lung Cancer Patients: From Prevention to Diagnosis and Treatment

Authors: --- ---
Book Series: Frontiers Research Topics ISSN: 16648714 ISBN: 9782889457076 Year: Pages: 94 DOI: 10.3389/978-2-88945-707-6 Language: English
Publisher: Frontiers Media SA
Subject: Medicine (General) --- Oncology
Added to DOAB on : 2019-01-23 14:53:43
License:

Loading...
Export citation

Choose an application

Abstract

Approximately 40% of lung cancer patients will develop central nervous system (CNS) metastases during the course of their disease. Most of these are brain metastases, but up to 10% will develop leptomeningeal metastases. Known risk factors for CNS metastases development are small cell lung cancer (SCLC), adenocarcinoma histology, epidermal growth factor receptor (EGFR) mutant or anaplastic lymphoma kinase (ALK) rearranged lung cancer, advanced nodal status, tumor stage and younger age. CNS metastases can have a negative impact on quality of life (QoL) and overall survival (OS). The proportion of lung cancer patients diagnosed with CNS metastases has increased over the years due to increased use of brain imaging as part of initial cancer staging, advances in imaging techniques and better systemic disease control. Post contrast gadolinium enhanced magnetic resonance imaging (gd-MRI) is preferred, however when this is contra-indicated a contrast enhanced computed tomography (CE-CT) is mentioned as an alternative option. When CNS metastases are diagnosed, local treatment options consist of radiotherapy (stereotactic or whole brain) and surgery. Local treatment can be complicated by symptomatic radiation necrosis for which no high level evidence based treatment exists. Moreover, differential diagnosis with metastasis progression is difficult. Systemic treatment options have expanded over the last years. Until recently, chemotherapy was the only treatment option with a poor penetration in the CNS. Angiogenesis inhibitors are promising in the treatment of primary CNS tumors as well as radiation necrosis but clinical trials of anti-angiogenic agents in NSCLC have largely excluded patients with CNS metastases. Furthermore, research has also focused on methods to prevent development of CNS disease, for example with prophylactic cranial irradiation. Recently, checkpoint inhibitors have become available for NSCLC patients, and tyrosine kinase inhibitors (TKIs) have improved prognosis significantly in those with a druggable driver mutation. Newer TKIs are often designed to have better CNS penetration compared to first-generation TKIs. Despite advances in treatment options CNS metastases remain a problem in lung cancer and cause morbidity and mortality.This Research Topic provides an extensive resource of articles describing advances in CNS metastases management in lung cancer patients, from prevention to diagnosis and treatment.

Listing 1 - 10 of 63 << page
of 7
>>
Sort by